A Nanodrug Consisting Of Doxorubicin And Exosome Derived From Mesenchymal Stem Cells For Osteosarcoma Treatment In Vitro.

Hongxiang WeiJinyuan ChenShenglin WangFeihuan FuXia ZhuChaoyang WuZhou-Jie LiuGuangxian ZhongJianhua Lin

Published in: International journal of nanomedicine (2019)

The prepared Exo-Dox could be used as an excellent chemotherapeutic drug for treatment of osteosarcoma in vitro. Considering the tumor-homing feature of BM-MSCs, the Exo-Dox may be a good candidate for targeted osteosarcoma treatment in future study.

Keyphrases

mesenchymal stem cells
machine learning
drug delivery
cancer therapy
combination therapy
current status
adverse drug
smoking cessation
electronic health record